Alyeska Investment Group’s LianBio American Depositary Shares LIAN Stock Holding History
Bought
Maintained
Sold
Other funds holding LIAN
PA
VA
TCM
VVA
SG
Alyeska Investment Group's LIAN Position: Q4 2022 in Review
Alyeska Investment Group sold out of LianBio American Depositary Shares (LIAN) in Q4 2022, closing a stake of 429,186 shares — an estimated $858K sold.
Alyeska Investment Group first reported a position in LIAN in Q4 2021 and held it in 4 quarters. The position peaked at $1.75M in Q4 2021. 40 funds tracked by Wall St. Rank hold LIAN as of Q4 2022.
- Alyeska Investment Group reported no remaining LianBio American Depositary Shares position as of Q4 2022 after selling out during the quarter.
- Alyeska Investment Group sold 429,186 LianBio American Depositary Shares shares in Q4 2022, an estimated $858K.
- Alyeska Investment Group first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 4 quarters.
- Alyeska Investment Group's LianBio American Depositary Shares position peaked at $1.75M in Q4 2021.
- 40 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2022.
Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.